Clinuvel Pharmaceuticals Ltd
ASX:CUV
Wall Street
Price Targets
CUV Price Targets Summary
Clinuvel Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for
CUV
is 26.94 AUD
with a low forecast of 16.16 AUD and a high forecast of 48.62 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CUV's stock price target?
Price Target
26.94
AUD
According to Wall Street analysts, the average 1-year price target for
CUV
is 26.94 AUD
with a low forecast of 16.16 AUD and a high forecast of 48.62 AUD.
What is Clinuvel Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Clinuvel Pharmaceuticals Ltd's revenue is
48%.
The projected
CAGR
for the next 3 years is
11%.
What is Clinuvel Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
6%
The
compound annual growth rate
of Clinuvel Pharmaceuticals Ltd's operating income for the next 3 years is
6%.
What is Clinuvel Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
12%
The
compound annual growth rate
of Clinuvel Pharmaceuticals Ltd's net income for the next 3 years is
12%.
You don't have any saved screeners yet
